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ABSTRACT 
Genomic instability and acquisition of invasiveness through the basement membrane 
extracellular matrix (ECM) are two major processes for epithelial cell malignancy in 
breast cancer. DNA double-strand break repair (DSBR) is one of the processes that get 
misregulated during breast cancer progression. In addition, radiation induced breaks 
such as those induced during radiation therapy to treat breast cancer patients are 
repaired by DSBR, rendering this pathway relevant for therapy as well. DSBR can occur 
either by homologous recombination (HR) or non-homologous end-joining (NHEJ). HR 
is accepted as the more error-free pathway. HR is regulated by the cell cycle status 
such that an increase is observed in G2/M, whereas NHEJ is observed throughout the 
cell cycle. 
Previous data show that ECM signaling regulates HR, as well as the kinetics of ionizing 
radiation (IR) induced complex formation at break sites, or foci kinetics. Both human 
breast epithelial cell lines and primary mouse mammary epithelial cells were used to 
show that the ECM receptor β1-integrin is necessary and sufficient in down regulating 
HR, as well as IR induced foci formation kinetics for the DSBR proteins RAD51, 
MRE11, and γ-H2AX in single mammary epithelial cells. RAD51 is required for most 
HR, whereas MRE11 and γ-H2AX function in HR as well as DNA damage signaling. 
Interestingly, ECM signaling up-regulates HR in cells that have “correct” in vivo-like cell-
cell junctions. Based on the observation that single cells and junctioned cells respond to 
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ECM in exact opposite manner, I hypothesized that ECM signaling may interact with 
cell-cell junction signaling pathways in regulating DNA repair.  
To test this hypothesis, I asked whether the main breast epithelial adherens junction 
cadherin, E-cadherin, is involved. I blocked E-cadherin function using a monoclonal 
antibody MB2. The function blocking was demonstrated by the loss of cell-cell junction 
interactions and observation of increased cell scattering using phase microscopy. I then 
asked whether blocking E-cadherin altered the expression and localization of proteins 
related to DNA repair. Indirect immuno-fluorescence showed that in the E-cadherin 
blocked non-tumorigenic breast epithelial cell line HMT-3522 S1 there is an up-
regulation of nuclear γ-H2AX and RAD51, as well as an increase in the proliferation 
marker Ki67. In non-proliferative MB2 blocked cells there is an upregulation of γ-H2AX 
and reduced Ki67. Furthermore, in these proliferative and non-proliferative blocked cells 
we were able to see lower levels of β-catenin near the cell membrane and an increase 
in its levels inside the cell especially in the nucleus. The latter has been confirmed also 
by western blot technique comparing the nuclear and cytoplasmic fraction expression. 
In addition, western blots showed that total RAD51 level was down-regulated by E-
cadherin blocking and γ-H2AX levels were found to be higher in proliferative and non-
proliferative MB2 treated cells. MB2 treated cells have a higher frequency of HR in the 
absence of ECM and in the presence of ECM, MB2 blocking abolishes the ECM effect 
on HR. Furthermore, in the absence of ECM, RAD51 siRNA treated cells down-
regulated HR but the absence of RAD51 did not down regulate HR in the presence of 
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ECM. I was not able to see any difference in the phosphorylated forms of β-catenin 
such as Tyr-142, Ser-45 and Tyr-86 that has the ability to enter into the nucleus. 
Therefore, E-cadherin was found to block nuclear β-catenin, RAD51 and γ-H2AX in a 
proliferation-independent manner. E-cadherin also was necessary for ECM to up-
regulate HR. The up-regulation of HR by ECM was only slightly dependent on RAD51 
suggesting a novel E-cadherin-dependent and RAD51-independent HR component in 
breast epithelial cells in contact with ECM as they are in vivo in the normal breast 
tissue.  
These experiments will help us to understand the role of E-cadherin and β-catenin in 
DNA double-stand break repair directly, as well as in combination with ECM signaling. 
Both alterations in integrin mediated signaling and cell-cell junction integrity contribute 
to breast cancer progression by rendering breast epithelial cells more invasive. My 
project will shed light on whether these invasive processes also alter DNA repair and 
contribute to genome stability. Understanding of the interrelationships among integrin 
signaling, cell-cell junctions, and genome stability will contribute to understanding 
normal breast cell processes and open up investigations on how these may go awry in 
cancer progression.  
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INTRODUCTION 
Cells create the correct configuration of their microenvironment by secreting and 
manipulating extracellular matrix (ECM) components. ECM in turn serves as a support 
for the development of all structures that comprise a functional organism and are also 
involved in regulating inter-cellular communication. Cells recognize a functional ECM 
using mostly the major cell receptor, integrins. Integrins play a vital role in the alteration 
of cellular growth and tumor progression through the regulation of gene expression, 
apoptosis, cell adhesion, proliferation, migration, angiogenesis[1, 2] and proteinase 
secretion[3].  
EXTRACELLULAR MATRIX (ECM) 
In mammary glands, the epithelial cells reside on thin sheet-like structures of ECM 
known as the basement membrane (BM). Type IV collagen, laminin, heparin sulphate 
proteoglycans (HSPGs) and nidogen/entactin are some of the major components of BM. 
Type IV collagen is a major structural protein of BM. They are heterotrimers composed 
of three alpha chains. There are 6 genetically distinct alpha chains encoded by genes 
COL4A1 through COL4A6 located in chromosome 2q36, 13q34 and Xq22 (Figure1) [4].  
These alpha chains can arrange into at least three different forms viz., [α1(IV)]2α2(IV), 
[α3(IV)]2 α4(IV) and [α5(IV)]2α6(IV). [α1(IV)]2α2(IV) was found to be present ubiquitously 
in all BMs. Apart from this, α5(IV) and α6(IV) chains were found to be present in the BM 
of mammary gland [5]. In situ hybridisation and immunohistochemistry have revealed 
that assembly of α5(IV)/α6(IV) is defective in the invasive stages of breast cancer [6].  
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Furthermore, many isoforms also exist for these 6 forms of type IV collagen alpha 
chains further contributing for its diversity.  
Each type IV collagen chain consists of three domains: an N-terminal 7S domain, a 
middle triple-helical domain, and a C-terminal globular noncollagenous (NC1) domain 
(Figure 2). It is speculated that the triple-helical type IV collagen molecules self 
associate via their NC1 domains to form dimmers and also at the glycosylated N-
terminal 7S domain to form tetramer (lateral association). These interactions form the 
nucleus of type IV collagen scaffold which will further evolve into a type IV collagen 
suprastructure representing spider web-like scaffolds with the help of the end to end 
and lateral associations (Figure 3) [7].  
Laminin is a trimer containing α, β, and γ chains and are available in 12 different forms. 
Laminin is believed to initiate BM scaffold formation at the basolateral surface of the 
cells. Laminin polymer anchors to the cell surface via site-specific interactions with 
integrins (especially β1-integrins) and dystroglycans. The type IV collagen scaffold in 
turn associates with laminin polymers on the cell surface via nidogen/entactin bridging. 
[7]. 
Most of the knowledge on signaling and phenotypic consequences of BM was gained 
from the mouse Engelbrecht Holm-Swarm (EHS) sarcoma tumor secreted ECM used in 
culture.  
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These EHS cells produce and accumulate BM components within the tumor tissue that 
can be easily isolated [7, 8]. We use EHS (BD Matrigel™ Basement Membrane Matrix, 
Growth Factor Reduced) as ECM for our culture experiments. It is a solubilized 
basement membrane preparation extracted from the EHS mouse sarcoma, a tumor rich 
in extracellular matrix proteins that has laminin, collagen IV, heparan sulfate 
proteoglycans, and entactin/nidogen. BD Matrigel Matrix also contains TGF-β, 
epidermal growth factor, insulin-like growth factor, fibroblast growth factor, tissue 
plasminogen activator and other growth factors which occur naturally in the EHS tumor. 
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Figure 1: Collagen genes in human. The location of six different genes that encodes 
for genetically distinct alpha chains of collagen. The collagens are located in pairs and 
in opposite orientation (head-to-head fashion) on three different chromosomes. The 
different collagen genes are represented in different colors (Adapted from J Biol chem 
268(35), 1993, pp. 26033–6, [4]). 
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Figure 2. Schematic model of a type IV collagen. Three alpha chains are arranged to 
form type IV collagen and is represented in the figure as single thick horizontal blue bar 
for simplicity. It contains three domains. The triple-helical domain consists of ~1400 
amino acids (aa) and consists of 22 imperfections within the Gly-X-Y motif. The NC1 
domain is ~230 amino acids in length (Adapted from Nat Rev Cancer, 3(6), 2003, pp. 
422–33, [7]).   
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Figure 3. Formation of Type IV collagen network. Two NC1 domain associate to 
form dimer while four 7S domain associate to form a tetramer. The dimer and tetramer 
forms the nucleus for the Type IV collagen scaffold formation (Adapted from Nat Rev 
Cancer, 3(6), 2003, pp. 422–33 [7]).   
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INTEGRINS 
Integrins are the major cell receptors that interact with ECM. They are heterodimeric 
transmembrane receptors composed of α and β subunits [9]. There are 24 heterodimers 
of integrin family formed from 18 α and 8 β subunits. Within this integrin family β1- 
integrins, β2-integrins and αv-containing integrins are the 3 largest groups (Figure 4). 
Different integrins can bind to different ECM components while some integrins can bind 
to many ECM components. For instance, α1β1, α2β1, α5β1 integrins bind to collagens, 
α6β4, α3β1 integrins binds to laminins and α8β1 binds to fibronectin, vitronectin and 
nephronectin. Furthermore, the interactions between integrins and BM components are 
altered when there is a structural change in BM components. For example, α1β1 and 
α2β1 integrins bind to collagen IV and promote proliferation and migration in cells. But 
when the collagen is degraded by MMP, αvβ3 integrin binds to the denatured collagen 
IV but not α1β1 and α2β1 integrins.  
Integrins can signal bidirectionally [10]. They can get information from extracellular 
stimuli to induce intracellular changes (outside-in signaling) or from intracellular stimuli 
to induce extracellular changes (inside-out signaling). The activation of integrins occurs 
through inside-out signaling [11]. Normally integrins are expressed on the cell surface in 
an inactive conformation, unable to productively bind to ECM. Through inside-out 
signaling, talin binds to the cytoplasmic domain of integrin causing structural changes in 
the extracellular domain of integrin leading to integrin activation [12]. This activation 
increases the affinity of individual integrin for ECM ligands. Ligand-bound integrins 
cluster first into unstable structures called nascent adhesions [13].  A subset of nascent 
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adhesions progresses to dot like focal complexes, which can mature into larger focal 
adhesions (FAs) and finally into streak-like fibrillar adhesions [14]. Once integrins are 
activated and clustered they are able to transmit many intracellular changes by outside-
in signaling and this occurs by the recruitment of Rho GTPases, Raf, Ras, FAK, and 
MAPKs such as extracellular-signal-regulated kinases (ERKs) to the ECM ligand-
integrin binding site [15]. 
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Figure 4. Representation of the integrin family. In vertebrates, the integrin family 
contains 24 heterodimers. Different sets of integrin receptors bind to different 
components of ECM (Adapted from Cell Tissue Res, 339, 2010, pp. 269–80, [16]).   
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INTEGRINS AND CADHERINS 
Various studies report a correlation between cell-ECM and cell-cell adhesions. In colon 
cancer, inhibition of E-cadherin caused an up-regulation of α5 integrins [17]. In addition, 
introduction of a dominant negative mutant E-cadherin into keratinocytes resulted in 
reduction in expression levels and activity of α2β1 and α3β1 integrins [18, 19]. In 
another study, introduction of E-cadherin to Xenopus-derived fibroblasts caused 
downregulation of α3β1 integrin and reduced adhesion to fibronectin and laminin [20]. 
Furthermore, functionally inhibited-anti-cadherin antibodies have been shown to prevent 
loss of α6 and β1- integrin in terminally differentiated keratinocytes [21].  
Various experiments also have shown the effect of E-cadherin on the downstream 
factors of integrin. For instance, ILK involved in integrin signaling pathway was reported 
to promote β-catenin translocation to the nucleus while β-catenin through its 
downstream factor TCF/LEF regulates the promoter for cyclin D1 [22, 23]. The above 
evidences suggest that there is some cross talk between integrin signaling and E-
cadherin pathway and are summarized in Figure 5. Previous results show that β1- 
integrin mediated ECM signaling downregulates the homologous recombinational repair 
of double-strand breaks in single cells but has the opposite effect in junctioned epithelial 
cells [24], suggesting a cross-talk between cell-cell junction and ECM signaling that 
functions in double-strand break repair. Here we study cell-cell junction signaling 
involvement in double-strand break repair, focusing on adherens junctions previously 
shown to interact with ECM signaling pathways.  
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Figure 5. Relationship between E-cadherin and integrins in different cell lines 
([17], [18, 19], [20], [21], [22, 23]).    
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E-CADHERIN PATHWAY 
Cadherins are one of the major proteins involved in cell-cell adhesion by forming 
adherens junctions (AJ) between cells. Cadherins are also involved in regulating cell 
shape, segregation, migration, proliferation and differentiation [25]. Within the cadherin 
family of proteins, E-cadherin is found at the junctions of epithelial cells and mediates 
cell-cell adhesion through homophilic interactions of their extracellular domains. E-
cadherin also mediates contact inhibition of cell growth [26]. A reduced E-cadherin 
expression was observed in at least 41% of human lobular breast carcinoma cases 
mainly due to hypermethylation of E-cadherin promoter region [27].   
The cytoplasmic tail of E-cadherin was found to interact with various proteins such as β-
catenin and alpha-catenin that link E-cadherin receptor indirectly to cell signaling and 
trafficking [28]. Furthermore, it is proposed that the E-cadherin/β-catenin interaction 
occurs in the ER (endoplasmic reticulum) and is required for cadherin exit from ER. 
Normally in the absence of Wnt signal, the cytosolic levels of β-catenin are low due to 
sequential phosphorylation of serine and threonine residues of β-catenin by GSK3β 
(glycogen synthase kinase-3β) and CK1 (casein kinase 1) within MDC (multiprotein 
destruction complex) followed by proteasomal degradation [29]. In the presence of Wnt 
ligand (secreted lipid-modified signaling protein); the receptor is activated causing MDC 
to destabilize. As a result, the unphosphorylated β-catenin accumulates in the cytosol 
and is subsequently translocated into the nucleus where it associates with TCF/LEF (T 
cell factor/lymphoid enhancer factor) transcription factor. This leads to transcription of 
Wnt target genes [30] (Figure 6). 
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In addition, CCN6, a Wnt1 induced signaling protein 3 knock down in benign human 
mammary epithelial cell lines (HME and MCF10A) led to down regulation of E-cadherin 
[31]. 
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Figure 6. The Wnt Pathway. β-catenin is the main protein involved in the pathway and 
the fate of this protein changes in the presence and absence of Wnt signaling (Adapted 
from J. Hülsken, MDC, Berlin [32]). 
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DOUBLE STRAND BREAK REPAIR AND CELL-CELL JUNCTIONS 
Genomic instability is one of the main properties of malignant cell that lead to 
acquisition of various forms of mutations. To maintain a stable genome, DNA double-
strand breaks (DSB) caused by ionizing radiation and DNA damaging chemicals should 
be repaired. DSBs can be repaired by major repair pathways such as homologous 
recombination (HR) or non homologous end joining method (NHEJ) (Figure 7). HR is 
known for its error-free repair when compared to NHEJ [33]. Furthermore, HR is 
predominant during S and G2 phase while NHEJ is upregulated during G1 phase of the 
cell cycle [34]. 
In NHEJ, the DNA ends are processed to produce ligatable ends after which the ends 
are ligated. In case of HR, the DSBs are first sensed by the MRN complex of proteins. 
The MRN complex is a hetero-trimeric protein consisting of MRE11, RAD50 and NBS1.  
MRE11 has DNA-binding domains and a domain with exonuclease activity that can also 
interact with NBS1. NBS1 also has exonuclease activity and contains domains that 
interact with MRE11 and ATM. RAD50 has walker A and B. Walker A and B are 
separated by coiled-coil domains with a zinc-hook motif in the center (Figure 8)[35, 36]. 
When there is a DSB, MRE11 binds to the broken DNA ends through its DNA-binding 
domain. NBS1 is recruited to this site as MRE11 contains an NBS1 binding domain. 
RAD50 through its walker A and B tethers the DNA ends. Interaction of RAD50 with 
MRE11 stimulates endonuclease activity of MRE11 in order to processes the DNA ends 
to produce 3’overhangs.  Recruitment of ATM as inactive dimer at DSB also occurs 
after the assembly of MRN complex. Both by RAD50 that increases the local 
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concentration of DNA ends and NBS1, the ATM gets activated into an active monomer 
which in turn phosphorylates a number of substrates that are involved in HR and NHEJ, 
including H2AX to γ-H2AX by phosphorylating H2AX at ser139 (Figure 9)[35]. γ-H2AX 
forms foci at and near the DSBs and also acts as a docking site for the DNA repair 
proteins.  
In addition to the MRN complex, also BRCA1 and CtIP are involved in the activation of 
HR-mediated repair of DNA in the S and G2 phases of the cell cycle. After end 
resection the 3’ overhangs invade the sister chromatids. These single stranded DNA 
binds to single stranded binding protein, RPA (replication protein A). RAD51 binds to 
the RPA bound ssDNA with the help of mediators and forms a nucleoprotein filament. 
This is followed by strand invasion, synthesis of DNA by DNA polymerase and 
resolution of junctions (Figure 9)[35].  
Apart from the above explained HR that involves RAD51, there is also an RAD51-
independent HR that has been widely studied in S. cerevisiae. RAD51-independent 
recombination pathway (RIRP) was predicted to occur by invasion of 3’end of the 
broken chromatid into an intact non-homologous chromosome leading to non-reciprocal 
translocations (Figure 10)[37]. Interestingly, in mammalian cells, a research group while 
studying the effects of HR on cells expressing mutant RAD51, they were able to see 
some residual level of HR taking place within these cells suggesting that there could be 
a RAD51 independent recombination pathway in mammalian cells as well [38]. 
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Figure 7. The double strand break repair pathway. Picture showing the different 
possibilities by which DNA double strand breaks can be repaired and their mechanisms 
are explained in diagrammatic manner. 
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Figure 8. Structure of RAD50. RAD50 contains two coiled-coil domains and a zinc 
hook. There is walker A and B that are present at either ends of RAD50 molecule that 
helps in tethering the broken DNA ends. (Adapted from J Appl Genet 49(4), 2008, pp. 
383–396) [35, 36].   
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Figure 9. Diagrammatic representation of double strand DNA repair. Left panel, 
MRN complex is the first one to sense the double strand break before RPA and RAD51. 
Right panel, a detailed function of all the three proteins of MRN complex (adapted from 
J Appl Genet 49(4), 2008, pp. 383–396 [35]).  
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Figure 10. RAD51-independent HR pathway. Figure shows a possible pathway by 
which DNA double strand break can be repaired in a RAD51 independent manner 
(adapted from Genetics, 158(3), 2001, pp. 959 -72 [37]).  
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HUMAN BREAST EPITHELIAL CELL LINE MODEL 
As a model for breast epithelial cells, S1 and S1 DR9 cells will be used in the 
experiments. These breast epithelial cells were derived from a reduction-mammoplasty 
specimen of a patient with fibrocystic breast disease and grown on a defined medium to 
obtain HMT-3522 S1 cells (referred to as S1 cells from here on) [39]. S1 cells are 
immortalized but non-tumorigenic when injected into nude mice [40]. Most importantly 
for this project, S1 cells are dependent on the Epidermal Growth Factor (EGF) for 
growth. Leaving out EGF from the growth media arrests the cells mostly in the G1 
phase of the cell cycle (Figure 11). Double-strand break repair pathway frequency has 
been shown to depend on which phase of the cell cycle the cells are in. Therefore, by 
simply not providing EGF to cells, they can be stopped in G1 phase. HR is high in G2/M 
phase. But since we use a GFP direct repeat sequence in S1 DR9 cells, we are able to 
observe intrachromatid recombination events in G1 (Figure 12). This helps us to do 
experiments on HR frequency that are reproducible as all cells will be in one phase of 
cell cycle.  
S1 DR9 cells are normal S1 cells into which two direct repeats of non-functional GFP 
gene (DR-GFP) have been integrated [41]. The DR-GFP is integrated in the hprt 
(hypoxanthine phosphoribosyl transferase) locus. The DR-GFP has a 5’s-GFP gene 
that has a rare I-SceI endonuclease recognition site of 18bp length within it. DR-GFP 
also has a 3’iGFP gene that has 0.8Kb homology for reparing the I-SceI cleaved s-GFP 
and to restore its expression through homologous recombination, specifically by non-
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crossover gene conversion. This can occur between sister chromatids or by 
intrachromosomal recombination (Figure 12).  
But the GFP gene expression will not be restored if the double-strand break (DSB) is 
repaired by non-homologous end joining method (NHEJ) (Figure 13). Thus the 
expression of GFP reporter is used as a measure of homologous recombination. In 
order to induce the break at the I-SceI recognition site, plasmid pBAS that expresses 
the I-SceI endonuclease from an actin promoter is introduced into S1 DR9 cells. To 
compare the transfection efficiency, a plasmid expressing GFP from the same promoter 
is transfected into cells in parallel under the same experimental conditions.  
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Figure 11. Percentage of non-proliferative S1 cells at different phases of cell 
cycle. When the normal S1 cells with cell-cell junctions are treated with growth medium 
without EGF, mostly the cells were found to be in G0 or G1 phase of cell cycle while 
only a very low percentage of cells were in other phases of cell cycle after DSB 
induction for up to 9 days. 
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Figure 12. Possible DSB repair mechanisms at different phases of cell cycle. 
During Go and G1 phase intrachromosomal recombination occurs to repair DSB by HR 
while sister chromatid exchange occurs during G2, M and S phase of cell cycle. 
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Figure 13. Assay for homologous recombinational repair of an induced DSB 
within a direct-repeat substrate, DR-GFP assay.  
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EFFECT OF ECM ON HR IN JUNCTIONED CELLS 
Previously in our lab, DSB was induced in S1 DR9 cells by transfecting the I-SceI 
endonuclease encoding pBAS after the cells formed cell-cell junctions (approximately 
40% confluence). In the presence of ECM, the percentage of GFP positive S1 DR9 cells 
increased indicating an up-regulation of HR as compared to its down-regulation in the 
absence of ECM (Figure 14). The results were also consistent with primary mouse 
epithelial cells with proper junctions. Furthermore, similar results obtained for non-
dividing S1 DR9 cells that have normal cell-cell junctions showing that the result is not a 
secondary consequence of the effects of ECM on cell cycle.   
EFFECT OF ECM ON HR IN SINGLE CELLS 
Interestingly, single S1DR9 cells as compared to junctioned cells, ECM was found to 
have an opposite effect. That is, HR was up-regulated in the absence of ECM and it 
was down-regulated in the presence of ECM (Figure 15). Thus there were reciprocal 
results for the effect of ECM on HR in the presence of normal cell-cell junction and in 
single cells without in-vivo like cell-cell junction.   
EFFECT OF ECM ON DNA REPAIR PROTEIN FOCI FORMATION AFTER IONIZING 
RADIATION 
Foci formation kinetics of S1 cells show that the effects of ECM via β1-integrin on DNA 
repair proteins such as H2AX and RAD51 is modulated by ECM (Figure 16). In primary 
mouse mammary epithelial cell organoids, in the presence of ECM, β1-integrin and cell-
cell junction, γ-H2AX levels were up regulated. But in single S1 cells (absence of cell-
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cell junction), γ-H2AX and RAD51 is down-regulated in the presence of ECM and β1- 
integrin (Figure 16).   In addition, MRE11 foci kinetics is altered by ECM in single cells 
(Figure 16). These results suggest that cell-cell junctions alter the effect of ECM and 
ionizing radiation induced foci formation. In addition γ-H2AX, RAD51 and MRE11 
complex of proteins are candidates to test for nuclear modulated effect on HR.  
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Figure 14. Effect of ECM on HR in proliferative and non-proliferative cells. The 
number of GFP positive cells is directly related to HR frequency. And the GFP positive 
cells in the presence and absence of ECM and EGF were shown in the bar graph. 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Figure 15. Non-Tumorigenic Human Cell Line S1, Single Cells. In case of S1DR9 
cells that were stopped from proliferation immediately after seeding the cells, the cells 
remain single on the culture flask. The frequencies of HR for single and normal 
proliferating cells were compared in the presence and absence of ECM.  
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Figure 16. Ionising radiation induced foci kinetics of γH2AX, MRE11 and RAD51. 
Foci formation kinetics of cells after 3Gy, in the presence or absence of ECM or A2BII 
β1-integrin blocking antibody at 100µg/ml for S1 and Ha2/5 at 10µg/ml for mouse cells.  
*,t-test p<0.05 and significant. 
32 
 
 
 
HYPOTHESIS 
Previously, ECM signaling via β1-integrin was shown to up-regulate homologous 
recombination (HR) in the presence of normal cell-cell junctions whereas it down-
regulated HR in the absence of junctions in single cells. This led us to ask whether cell-
cell junctions modulate the effects of ECM on homologous recombination. Specifically, 
we hypothesize that adherens junction signaling that has intersecting signaling 
components with ECM signaling can modify the ECM effect on HR. 
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METHODS AND MATERIALS 
CELLS USED 
S1 cells (normal mammary epithelial cell line) were used for western blotting and 
indirect immunofluorescence techniques [40, 42]. S1 DR9 cells were used for all flow 
cytometry analysis. Since, S1 DR9 cells contain two direct repeats of non-functional 
GFP genes and when a double-strand break is induced within the GFP gene at I-SceI 
recognition site and if the break is repaired by homologous recombination then the GFP 
gene becomes functional [24, 43]. Therefore, to measure the frequency of homologous 
recombination, I used these cells. 
PLASMIDS AND siRNA USED AND THEIR TRANSFECTION 
pBAS plasmid and pGFP plasmids were used for DR-GFP experiments [24]. pBAS 
encodes for I-SceI endonuclease. pGFP encodes GFP protein and are used as positive 
control as well as to measure the transfection efficiency. Both the plasmids are resistant 
to ampicillin. These plasmids were amplified by first transforming them into competent 
E. coli cells. The transformed E.coli cells were plated on LB agar containing ampicillin 
and incubated overnight at 37ºC in order to select the transformed cells. Individual 
colony of cells containing the plasmid were further amplified first in 3ml and then in 
250ml LB liquid medium containing ampicillin by incubating them at 37ºC overnight in a 
shaker at 250rpm. Then the plasmids were isolated using Maxiprep (Qiagen) for 
transfection into mammalian cells (jetPEI transfection reagent, polyplus). siRNA against 
35 
 
 
 
RAD51 (siGENOME SMART pool of human RAD51, Dharmacon) was used in HR 
experiments. 90 µl (20 µM) of RAD51 siRNA or scramble control siRNA was transfected 
into S1 cells in T-75 flask using 75 µl of Dharmafect transfection reagent. 
ANTIBODIES 
RAD51 from Calbiochem (Cat. No. Ab-1, PC130, 1:1000 dilution) and Novus (Cat. 
No.13E4, 1:5000 dilution) have been used for indirect immunostaining and western blot. 
Ki67 from Novocastra (Cat. No. NCL-Ki67p (Ki67p-CE), 1:100 dilution) or Calbiochem 
(Cat No., 1:100 dilution) was used for indirect immunofluorescence. β‐catenin (Cat. No. 
BD: 610153, BD biosciences, 1:50 dilution) and γH2AX (Clone JBW301, Millipore, Cat. 
No. 05-636, 1:75) were used for both indirect immunofluorescence technique. E-
cadherin from Abcam (Clone MB2, Cat. No. ab8993) was used as blocking antibody 
and She7-78 from Axxora (Cat. No. ALX-804-203, 1:150 dilution supplemented with 
10mM calcium chloride) was used for indirect immunofluorescence. NBS1 (Cat. No. BD: 
611870, 1:100 dilution), RAD50 (Cat. No. BD: 611010, 1:500 dilution) and MRE11 (Cat. 
No. BD: 611367, 1:250 dilution) from BD transduction laboratory, α-tubulin from Sigma 
(Cat. No. T6074-200Ul, 1:1000 dilution) and Lamin B (Santa Cruz, Cat. No. sc-6216, 
clone C20, 1:200 dilution) were used in western blotting.  
INDIRECT IMMUNOFLUORESCENCE 
To study the expression of DNA repair proteins on MB2 treated and control cells, I did 
indirect immunofluorescence technique. For this 40,000 S1 cells were plated on each 
well of a 4-well chambered slide and incubated for 3-4 days. Once the cells formed cell-
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cell junctions, cells in each well were treated with MB2 at three different increasing 
dilutions (1, 2 and 5µg/ml) and one well was used as control (MB2 untreated). After 
treatment, the cells were incubated for another 48 hrs. Then the cells were subjected to 
indirect immunofluorescence technique. For this, the cells were washed with PBS (pH 
7.4) and were treated with 0.5% triton-100 in CSK buffer (100 mM NaCl, 300 mM 
sucrose, 10 mM Pipes, 5 mM MgCl2, 0.25 mM NaF) with protease inhibitor (1:1000 
dilution) for 10 min on ice. Then they were washed twice using CSK buffer containing 
protease inhibitor for 5 min each and fixed using 4% paraformaldehyde in CSK buffer 
(pH 7.4) at room temperature for 20 min followed by washing thrice for 20 min with 
PBS/glycine. Further, the cells were blocked for 1 hour using 10% goat serum in IF 
buffer. Primary antibodies were mixed with the blocking solution and dispensed into the 
wells. Then the chambered slides were wrapped with parafilm and placed in humidified 
chamber at 4ºC overnight to avoid drying of the antibody solution. Next day, the slides 
were washed thrice with IF buffer for 20 min with gentle agitation followed by secondary 
antibody treatment (1:400 dilution) for 1 hour in dark. Then the slides were washed 
thrice using IF buffer for 20 min followed by nuclear attaining using DAPI (1:10000 
dilution from 10µg/ml stock solution) for 10 min. After 10 min of washing in IF buffer, 
coverslip was placed over the slide with Vectashield and viewed under the fluorescence 
microscope. Same amount of exposure time were used for each slide to view all 4 wells 
to compare the expression levels of DNA repair proteins in control and MB2 treated 
cells at different dilutions. 
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WESTERN BLOTTING 
S1 cells grown in T-75 flasks were treated with 5 µg/ml MB2 and incubated for 48 hours. 
Control cells were also grown simultaneously that were not treated with MB2. These S1 
cells (MB2 treated and untreated) were lysed to prepare whole cell lysate and cytosolic 
and nuclear extracts. In order to prepare whole cell lysate, the cells were trypsinized 
using 0.25% trypsin for 10 minutes followed by the addition of SBTI (soy bean trypsin 
inhibitor) in 10ml DMEM/F12 medium. The cells collected by centrifugation were 
washed with PBS and lysed by sonication in 100µl of RIPA buffer (5 M NaCl, 1 M Tris-
HCl, 500 Mm EDTA, 2% SDS, 1% NP-40, 1% deoxycholate, 200 mM NaVO4, 250 mM 
NAF and protease inhibitor). Then the lysed cells were centrifuged at 12,000 rpm for 10 
min at 4ºC. Supernatant was decanted into a separate tube and stored at - 85ºC. Protein 
estimation was done for the whole cell lysate obtained using BIORAD Dc protein 
estimation kit with serially diluted BSA in water as standards. Following protein 
quantification of whole cell lysates, they were run in SDS PAGE gel and transferred 
overnight onto nitrocellulose membrane at 20 mA. The transferred blot was blocked for 
1 hour with 5% milk and 1% BSA in TBST (Tris buffered saline with 0.05% tween-20) 
and probed for a specific protein using a primary antibody in TBS/TBST buffer overnight 
at 4ºC. Membranes were then treated with anti-mouse/rabbit secondary antibody 
(1:5000 dilution) for 1 hour at room temperature and viewed under LICOR imager 
(Odyssey v1.2 software) at a wavelength of 700nm for anti-rabbit antibodies and 800nm 
for anti-mouse antibodies. The bands are quantified using Odyssey LICOR infrared 
imaging software v1.2.     
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γ-H2AX LYSATE PREPARATION AND WESTERN BLOTTING 
Cell monolayer in T-75 flask were first washed with PBS and then are scraped from the 
flask after spreading 500µl of laemilli buffer (working solution) on the surface of the 
flask. The working solution for laemilli buffer was prepared by mixing 4750ul Laemilli 
buffer (BioRad cat# 161-0737) in 250ul Hem buffer (2-mercaptoethanol from Fischer 
cat# 03446I-100) and by finally making up the volume to 10ml with water. The scraped 
cells in laemilli buffer were lysed using a sonicator and heated in a 100ºC water bath for 
7 min. The lysate was then spun at 14,000 rpm for 5 min and stored at 20ºC until 
loading it in the SDS PAGE gel. 
The lysate was spun at 14,000 rpm for 5 min before loading them in the 12% SDS 
PAGE gel. 30 µl of sample volume loaded per well and run at 60 V for 150 min. Then 
the gel was transferred on to the PVDF membrane (0.2 µm thick pore size). The PVDF 
membrane was first activated in methanol for ~1 min and washed in transfer buffer for 
3-5 min before using it for transferring by western blotting method. Then after 
transferring overnight at 20 mA for 740 min, the blot was washed in blocking buffer 
containing 1ml of 1% casein in 9 ml of PBS for 50 min -1 hour. Then the blot was 
incubated with the primary antibody (1:1000 dilution of γ-H2AX from Millipore, clone 
JBW301, catalogue no. 16-193) in blocking buffer at 4ºC overnight. Next day, the blot 
was washed with PBST (contains 200 µl Tween 20 in 1litre PBS) 4 times for 15 min 
each. The blot was treated with anti-mouse secondary antibody (1:5000 dilution) in the 
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blocking buffer for 1.40 hours and washed again with PBST 4 times for 15 min before 
scanning.  
TOTAL AND ACTIVATED β1- INTEGRIN EXPRESSION ON CELL SURFACE 
S1 cells were trypsinized and 500,000 cells were taken in 10 microcentrifuge tubes. Out 
of ten, one tube was used as control without primary and secondary antibody treatment, 
three was used as secondary control (treated just with secondary antibody and not 
primary antibody) to subtract the background effect due to seconday antibody, three 
was used for probing total β1‐integrin and remaining three for probing activated β1‐ 
integrin levels in cells. The cells were first centrifuged at 8000 rpm for 5 min to remove 
the growth medium. Then the cell pellet was washed with 1 ml of FACS buffer (5% FBS 
and 0.1% sodium azide in 100 ml PBS) thrice by resuspending in FACS buffer and 
centrifuging at 5000 rpm for 5 min. Then the cells were treated with 50 µl of primary 
antibody (either total or activated β1‐integrin) in FACS buffer at 1:10 dilution for 1 hour. 
This mixture was then re-suspended every 15-20 min up to 1 hour. The cells were 
washed thrice in FACS buffer by re-suspending the cell pellet in 1 ml FACS buffer and 
centrifuging the cells at 5000 rpm for 5 min. Then the cells were treated with 50µl of 
secondary antibody in FACS buffer at 1:100 dilution for 30 min. The mixture is re-
suspended every 15 min during secondary antibody treatment. Later, the cells were 
washed with 1ml FACS buffer thrice as before. The cells were fixed by resuspending 
the cell pellet in 100 µl of 2% paraformaldehyde in PBS at pH 7 and stored at 4ºC. The 
cells were suspended in 500 µl PBS before running on flow cytometer.   
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RESULTS 
E-CADHERIN BLOCKING AND CONFIRMATION 
Since ECM has a reciprocal effect on HR in the presence and absence of cell-cell 
junctions I was interested to know the effect of cell-cell junctions on DNA repair 
proteins. As E-cadherin is the major protein that is involved in adhesion of adjacent 
breast epithelial cells together I tried to find out whether this cell-cell junction protein is 
the one that is responsible for the reciprocal effect on HR. To do this, I used MB2 
antibody. MB2 blocking antibody specifically reacts with 80 KD trypsin-resistant 
extracellular domain of E-cadherin that is present on the cell surface. When S1 cells at 
~40% confluence are treated with 5 µg MB2 antibody per ml of H14 growth medium 
containing EGF and incubated for 48 hours, S1 cells were found to be scattered. The 
adhesion between adjacent cells appeared to be less when compared to control cells 
under light microscope (Figure 17). Thus, MB2 antibody causes morphological changes 
in S1 cells that are consistent with diminished adherens junction function. When ~40% 
confluent S1 cells are treated with ECM, the cells look more compact than without ECM 
and in case of ECM and MB2 treated cells, the scattering was found to be lesser than 
cells treated with MB2 in the absence of ECM (Figure 17A).   
If ~40% confluent S1 cells were treated with H14 growth medium without EGF for 4 
days, the cells stop from proliferating (Figure 17B). When to these non-proliferating cells 
MB2 antibody was added (5 µg/ml, 48 hours), cell scattering was found to be lesser 
than in MB2 treated normal proliferative cells. The cell morphology of ECM and ECM 
plus MB2 treated non-proliferative cells are also shown in Figure 17B. 
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To further confirm that MB2 antibody blocks E-cadherin, I seeded S1 cells in a 4-well 
chamber slide and incubated until the cells form cell-cell junctions. Then cells in each 
well were treated with MB2 antibody at different concentrations (1 µg/ml, 2 µg/ml and 5 
µg/ml). After 48 hours of incubation the cells were fixed and indirect 
immunofluorescence was performed against E-cadherin on MB2 treated and untreated 
cells. Results showed that the control cells have a thin line of E-cadherin between two 
adjacent cells but it is absent in MB2 treated cells (Figure 18). The E-cadherin signal 
observed between two adjacent control S1 cells is due to the presence of homophillic 
interactions between E-cadherin of adjacent cells and this interaction is abolished in 
MB2 treated cells further confirming that MB2 blocks E-cadherin protein function at least 
after 48 hours (Figure 18).  
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A. PROLIFERATIVE CELLS (+EGF)         B.NON-PROLIFERATIVE CELLS (-EGF)  
 
 
Figure 17. Cell morphology of proliferative and non proliferative S1 cells with 
different treatments. A, changes in the morphology of proliferative cells with and/or 
without ECM and MB2 blocking. S1 cells were grown up to ~40% confluent by 
incubating for 3-4 days. ECM (10%) and/or MB2 blocking antibody (5 µg/ml) is added 
after the cells became 40% confluent and incubated for 48 hours. B, morphological 
changes in non-proliferative cells with and/or without ECM and MB2 blocking. S1 cells 
were grown up to ~40% confluent by incubating for 3-4 days and treated with growth 
medium without EGF for 4 days to stop them from proliferating. ECM (10%) and/or MB2 
blocking antibody (5 µg/ml) is added after the cells became 40% confluent and 
incubated for 48 hours.  
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Figure 18. Effect of E-cadherin blocking in S1 cells. The Top panel, DAPI staining; 
Bottom panel, corresponding E-cadherin staining. 5 µg/ml of MB2 antibody is the 
optimal concentration used to block S1 cells. 
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EFFECT OF E-CADHERIN ON DNA REPAIR PROTEINS IN PROLIFERATIVE CELLS 
As a next step, I was interested to find out whether E-cadherin is the cell-cell junction 
protein that is involved in modulating HR. For this, I tried to look at the effect of DNA 
repair proteins by blocking E-cadherin. Therefore, I treated the S1 cells with different 
concentrations of MB2 and after 48 hours of incubation the cells were fixed and indirect 
immunofluorescence was performed against DNA repair proteins γ-H2AX and RAD51. 
In addition, proliferative marker Ki67 was examined. β-catenin (protein that binds to the 
cytosolic domain of E-cadherin) localization was also determined since, its movement 
from the cell junction to the nucleus could have down-stream consequences in DNA 
repair either directly or indirectly via altering transcription or signaling events. 
Ki67 
Ki67 stains the nucleus of viable and proliferation-proficient cells. I was able to see 
22.6% (SD = +/- 0.1) positive cells in normal S1 cells (control). In MB2 treated cells 
(5µg/ml), 48% (SD = +/- 0.04) of cells were found to be positive (Figure 19). These 
results suggest that the MB2 treated cells have twice the amount of proliferative cells 
when compared to control cells. These results are consistent with a role for E-cadherin 
in reducing growth by contact inhibition and show that I blocked this E-cadherin function 
by MB2 treatment of S1 cells.  
46 
 
 
 
β-catenin: 
β-catenin is a protein that binds to the cytoplasmic domain of E-cadherin and connects 
E-cadherin to the actin cytoskeleton indirectly. It is also capable of entering into the 
nucleus and binding to the transcription factor TCF/LEF to up-regulate genes such as 
cyclinD and c-myc in response to Wnt signaling. In order to determine the effect of E-
cadherin blocking on β-catenin in S1 cells, we did indirect immunofluorescence. In 
control cells, β-catenin appeared to be around the inner side of the cell membrane 
attached to E-cadherin as expected but in MB2 treated cells β-catenin was more 
concentrated in the nucleus and was observed to be lining the inner side of the 
membrane attached to the cytosolic domain of E-cadherin (Figure 20). Considering cells 
that have β-catenin in the nucleus as positive cells, I was able see 12% (SD = +/- 0.03) 
positive cells in MB2 treated cells while control cells did not have any positive cells (0% 
SD = 0) (Figure 20).  
γ- H2AX: 
γ-H2AX is a DNA repair protein and can be seen as foci near double strand DNA 
breaks. Its foci formation kinetics in response to ionizing radiation was altered by ECM 
in opposite direction. In the presence and absence of cell-cell junctions, I determined if 
E-cadherin affects its expression or localization. These were done in the absence of 
ionizing radiation to determine if E-cadherin has effects on the basal levels of γ-H2AX. 
There were 17% (SD = +/- 0.08) of MB2 treated cells containing γ- H2AX foci but the 
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control cells did not have γ- H2AX foci in their nucleus (0%; SD = 0) (Figure 21) and this 
difference was significant (p = 0.03). These results suggest that either the basal level of 
DNA damage is increased or the cells have an altered basal state or concentration of 
DNA damage protein such as γ-H2AX in the absence of E-cadherin at cell-cell 
junctions. Alternatively, increased proliferation could increase proliferation could 
increase replication blocks and γ-H2AX foci.  
RAD51: 
RAD51 is required for most HR and was found to have altered foci kinetics by ECM 
signaling. To find out if it could be modulated by cell-cell junctions, I determined the 
effects of E-cadherin blocking on RAD51 levels in the absence of exogenous damage.  
Indirect immunofluorescence against RAD51 revealed 5% (SD = +/- 0.002) increase of 
RAD51 as large nuclear “foci” in MB2 treated cells when compared to control cells (0%, 
SD = 0) (Figure 22). The large blobs of RAD51 in the nuclei are not the typical foci 
observed after ionizing radiation. Whether these accumulations of RAD51 are active 
complexes or a means for storing inactive complexes remains an open question. 
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A.                                                                      B. 
   
Figure 19: Ki67 expression in normal and MB2 treated S1 cells. A, Top pannel, 
DAPI (nuclear) staining of control and MB2 treated cells respectively; Bottom pannel, 
Ki67 staining in control and MB2 treated cells. B, The average (mean) number of Ki67 
positive cells divided by the number of DAPI nuclei (y axis) in normal and in MB2 
treated cells at different concentrations (1 µg/ml, 2 µg/ml and 5 µg/ml) (x axis) were 
represented as bars. The error bars represent standard deviation of mean (N=2), with a 
minimum of 2 wells and 200 cells per well counted per experiment. p-value is calculated 
by comparing control and MB2 treated cells at 5 µg/ml concentration. 
 
 
 
 
p = 0.03 
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A.                                                                     B. 
     
 
Figure 20. Effect of E-cadherin blocking on β-catenin indirect 
immunofluorescence in S1 cells. A, Top panel, DAPI staining of control and MB2 
treated S1 cells. Bottom panel, β-catenin staining on control and MB2 treated cells. B, 
the average (mean) number of positive nuclei divided by number of DAPI in control cells 
as y-axis and cells treated with increasing concentrations of MB2 blocking antibody as 
x-axis. The error bars represent standard deviation of mean (N=2), with 2 wells and 
minimum of 200 cells counted per well in each experiment. p-value is calculated by 
comparing control and MB2 treated cells at 5 µg/ml concentration. 
 
 
 
p = 0.04 
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A.                                                               B. 
     
Figure 21. Indirect immunofluorescence of γ- H2AX on control and MB2 treated 
cells. A, Bottom panel, γ- H2AX staining on control and MB2 treated cells and their 
corresponding DAPI staining in the Top panel. B, shows a graphical representation of 
the average (mean) number of positively stained γ- H2AX nuclei divided by number of 
DAPI (y-axis) against different concentration of MB2 (x-axis). The error bars represent 
standard deviation of mean (N=2), with 2 wells and a minimum of 200 cells counted per 
well in each experiment. p-value is calculated by comparing control and MB2 treated 
cells at 5 µg/ml concentration. 
 
p = 0.03 
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A.                                                                      B. 
   
 
Figure 22. RAD51 expression on normal S1 cells and MB2 treated cells. A, Bottom 
panel, RAD51 indirect immunostaining. Top panel, DAPI staining for the control cells 
and MB2 treated cells. B, bar graph representing the average (mean) number of RAD51 
positive nuclei divided by DAPI (y-axis) in control and cells treated with increasing 
concentration of MB2 treatment (x-axis). The error bars represent standard deviation of 
mean (N=2), 2 wells and a minimum of 200 cells per well per experiment. p-value is 
calculated by comparing control and MB2 treated cells at 5 µg/ml concentration. 
p = 0.0004 
00.00.000 
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EFFECT OF E-CADHERIN ON DNA REPAIR PROTEINS IN NON-PROLIFERATIVE 
CELLS 
Previously, S1 cells were cultured in the presence of EGF and the effect of E-cadherin 
blocking was determined in dividing cells. Proliferation of MB2 treated cells was found to 
be higher than control cells as there was an increased Ki67 positive nucleus in MB2 
treated cells than control cells. It has been found that the levels of RAD51 are cell cycle 
regulated being lowest in G0/G1 phase, higher in S phase and the highest in G2/M 
phase [44]. γ-H2AX levels have been revealed to be 3x levels higher in G1 than in S or 
G2/M phase of unirradiated cells [45]. So, to find out whether increase in γ-H2AX and 
RAD51 in MB2 treated cells is due to proliferation or MB2 blocking, I performed indirect 
immunofluorescence in non proliferative cells.   
Ki67:  
Ki67 expression was low in all cells due to lack of EGF in growth medium of S1 cells. In 
control cells there were 8% (SD = +/- 0.08) positive cells and in MB2 treated cells 
(5µg/ml) there were 3% (SD = +/- 0.03) positive cells (Figure 25). The p-value for control 
and MB2 treated cells was not found to be significant. 
β-catenin: 
In non-proliferative cells, β-catenin (Figure 24) was found to be less near the membrane 
than in cytosol and / or nucleus in MB2 treated cells (1.4%, SD = +/- 0.02) when 
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compared to control cells (0%, SD = 0). This again confirms that E-cadherin function is 
blocked by MB2 antibody. Here, I found that MB2 treated non-proliferating cells also 
increased β-catenin nuclear positive cells. However, the number of positive cells having 
β-catenin in the nucleus of MB2 treated cells was lesser in non-proliferative cells when 
compared to proliferative cells.    
γ- H2AX: 
To ask whether the MB2 induced nuclear γ- H2AX in proliferating cells is due to 
increased proliferation or not, I did indirect immunofluorescence with non-proliferating 
S1 cells in the absence of EGF.  Interestingly, percent γ- H2AX foci containing nuclei 
were significantly higher in MB2 treated cells (15%, SD = +/- 0.2) than in control cells 
(0.1%, SD = +/- 0.002) in a way similar to proliferative cells (Figure 25). The number of 
γ- H2AX positive percent was comparable in proliferating and non-proliferating cells.  
Thus, this confirms that the increase in γ- H2AX levels in proliferative cells is not 
because of increased proliferation but as a consequence of MB2 blocking and due to a 
more direct effect on the DNA damage and repair pathway, including γ- H2AX 
phosphorylation. 
When the cells were treated with medium without EGF for 6 days instead of usual 4 day 
treatment, the γ- H2AX foci was seen in both control (34%, SD=+/- 0.4) and MB2 
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treated cells (38%, SD=+/- 0.5) to a similar extent. There was no significant difference in 
the γ- H2AX foci containing cell percentage between control and MB2 treated cells. But 
the foci were found to be larger in MB2 treated cells than in control cells. This qualitative 
observation needs to be further verified by foci size quantification in future experiments. 
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A.                                                                     B. 
   
Figure 23. Ki67 staining in non-proliferative cells. A, Top panel, DAPI staining. 
Bottom panel, Ki67 staining of control and MB2 treated cells. B, a bar graph 
representing average (mean) Ki67 positive nuclei divided by the number of DAPI (y-
axis) in control and increasing concentration of MB2 treated cells (x-axis). The error 
bars represent standard deviation of mean (N=2), with 2 wells and a minimum of 200 
cells per well per experiment. p-value is calculated by comparing control and MB2 
treated cells at 5 µg/ml concentration.   
 
 
 
 
 
p = 0.52 
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A.                                                                    B. 
  
Figure 24. Effect of MB2 on the localization of β catenin in non-proliferating S1 
cells. A, Top panel, DAPI staining. Bottom panel, β catenin staining of control and MB2 
treated cells respectively. B, the difference in the average (mean) number of nuclear β-
catenin positive cells divided by number of DAPI (y-axis) in control and increasing 
concentration of MB2 treated cells (x-axis). Positive cells are those that have β catenin 
staining in the nucleus. The error bars represent standard deviation of mean (N=2), with 
2 wells and minimum of 200 cells per well per experiment. p-value is calculated by 
comparing control and MB2 treated cells at 5 µg/ml concentration. 
 
 
 
p = 0.03 
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A.                                                             B. 
C.  D.  
               
Figure 25. γ- H2AX expression in non-proliferating S1 cells and MB2 treated cells. 
A and C, DAPI staining. Bottom panel, γ- H2AX staining of S1 cells (control) and MB2 
treated cells after 48 hours. A, S1 cells that are treated with growth medium without 
EGF for 4 days and C, 6 days. B and D, comparison of the average (mean) number of 
γ- H2AX positive nuclei divided by number of DAPI (y-axis) in control and with 
increasing concentration or 5 µg/ml concentration of MB2 treated cells (x-axis). The 
error bars represent standard deviation of mean (N=2), with 2 wells and a minimum of 
200 cells per well per experiment. p-value is calculated by comparing control and MB2 
treated cells at 5 µg/ml concentration. 
p = 0.04 
p = 0.9 
34% 38% 
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DETERMINING THE EFFECT OF E-CADHERIN ON DNA REPAIR PROTEINS BY 
WESTERN BLOT 
 To follow up on the localization results obtained by indirect immunofluorescence 
technique I did western blot to quantify RAD51, γ-H2AX and β-catenin in control and 
MB2 treated cells. In addition to this I also tried to find out whether there are any 
changes in the levels of NBS1, MRE11 and RAD50 in control and MB2 treated cells 
since, previously the MRE11 foci formation in response to ionizing radiation has also 
shown to be altered by ECM. As a first step, I prepared whole cells lysates from control 
and MB2 treated cells. For this I grew S1 cells up to ~40% confluence and treated them 
with MB2 blocking antibody (5 µg/ml). After 48 hours the cells were trypsinized and 
lysed. The whole cell lysates of normal S1 control cells and MB2 treated cells were run 
on an SDS PAGE and were examined for the presence of β-catenin (Figure 26), RAD51 
and γ-H2AX (Figure 27) and MRE11/RAD50/NBS1 (Figure 28).  
Results show no significant difference in the total β-catenin levels between the control 
and Mb2 treated cells. But both in proliferative and non-proliferative cells, nuclear β- 
catenin levels were found to be significantly higher than that of cytoplasmic extract in 
MB2 treated cells when compared to normal S1 cells (Figure 26). These results confirm 
the altered β-catenin localization in MB2 treated cells shown by indirect 
immunofluorescence method.  
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Total RAD51 levels were found to be significantly lower (Figure 27 A and B) in 
proliferative MB2 treated cells when compared to control cells (P = 0.04). Even though 
indirect immunofluorescence results showed an increased RAD51 “foci” in MB2 treated 
cells than control, the total RAD51 levels in MB2 treated cells were lower than in control. 
This suggested that the localization of the RAD51 is regulated independent of the 
protein levels overall. Whether the nuclear blobs of RAD51 represent active complex 
ready to repair or inactive complexes that need to be activated are two possibilities to 
be explored further.  
Furthermore, total γ-H2AX was found to be significantly higher in MB2 treated 
proliferative cells than untreated cells and results also showed that γ-H2AX levels were 
also found to be fluctuating in non-proliferative cells (Figure 27 C). The bands were 
quantified and normalized with α-tubulin loading control. The up-regulation of γ-H2AX in 
proliferating cells was more consistent than in non-proliferating cells. This may be 
possibly aided by the positive effect of MB2 on proliferation that increases γ-H2AX in S 
and G2/M phases of the cell cycle.  
There is no significant difference in the amount of MRE11, RAD50 and NBS1 proteins in 
control and MB2 treated cells either under proliferating or non-proliferating conditions 
(Figure 28).  
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A.                                                                                  B. 
 
C.                                                                                   D. 
 
Figure 26. β-catenin levels in MB2 treated and untreated cells. β-catenin levels in 
whole cell, cytosol and nucleus of proliferative cells (A 
, B) and non-proliferative cells (C,D). α- tubulin is used as control for whole cell lysate 
and cytosol extract, lamin B is used as control for nuclear extracts. B, the nuclear-to-
cytosolic ratio in control and MB2 treated cells. The error bars represent standard 
deviation of mean (N=3). D, a nuclear-cytosolic ratio of β-catenin in MB2 treated cells 
when compared to control cells. The error bars represent standard deviation of mean 
N
uc
le
ar
/ c
yt
os
ol
ic
 e
xt
ra
ct
 
N
uc
le
ar
/ c
yt
os
ol
ic
 e
xt
ra
ct
 
12 
10 
 8 
 6 
 4 
 2 
 0 
control  
 
 
Control  MB2 Treated 
Control  MB2 Treated 
p=0.03 
 p=0.04 
N=3 
N=2 
61 
 
 
 
(N=2). p-value is calculated for the bar graphs by comparing control and MB2 treated 
cells at 5 µg/ml concentration.    
 
 
 
 
Figure 27. RAD51 and γ- H2AX levels in control and MB2 treated cells. A, western 
blot probed for total RAD51 levels in control and MB2 treated cells. α-tubulin was used 
as a loading control. B, total RAD51 levels normalized by α-tubulin in control and MB2 
treated cells represented as a bar graph. RAD51/ α-tubulin was used a y-axis. The error 
bars represent standard deviation of mean (N=3). p-value is calculated by comparing 
control and MB2 treated cells at 5 µg/ml concentration. C, a sample blot containing 
normal and MB2 treated whole cell lysate from proliferative and non-proliferative cells 
probed for γ- H2AX levels.  D, α-tubulin normalized γ- H2AX levels in control and MB2 
treated cells. The error bars represent standard deviation of mean (N=2). p-value is 
calculated by comparing control and MB2 treated cells at 5 µg/ml concentration.   
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Figure 28. MRN complex of proteins in control and MB2 treated proliferative cells. 
A, a representative western blot of control and MB2 treated lysates collected from 
proliferative and non-proliferative S1 cells. The lysates were probed for RAD50, NBS1 
and MRE11 and α-tubulin was used as loading control. B, C and D, levels of NBS1, 
RAD50 and MRE11 respectively in control and MB2 treated proliferative (+EGF) and 
non-proliferative (-EGF) cells.  The error bars represent standard deviation of mean 
(N=4 for proliferative cells and N=3 for non-proliferative cells). p-value is calculated by 
comparing control and MB2 treated cells at 5 µg/ml concentration.   
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EFFECTS OF E-CADHERIN ON β1-INTEGRIN EXPRESSION AND ACTIVATION 
Previously, β1‐integrin blocking in single cells was shown to abolish the ECM effect on 
HR, as well as on foci formation in response to ionizing radiation. Combined with data in 
the lietrature that E-cadherin pathway can alter integrin expression and activation I 
wanted to determine the effect of E-cadherin blocking on cell surface β1‐integrin 
expression and activation by immunostaining non-permeabilized cells, as well as the 
total protein levels by western blot. 
 β1‐integrin cell surface expression in control and MB2 treated cells was not significantly 
different either in proliferating or non-proliferating conditions (Figure 29 A, B, C and D). 
The total levels of β1‐integrin in control and MB2 treated proliferative and non-
proliferative cells measured by western blot also showed no significant difference 
(Figure 29 E and F), showing that E-cadherin has no effect on β1‐integrin expression, 
localization, or activation. 
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A.                                              B.                                             C. 
  
D.                                              E.                                              F.  
   
 
Figure 29. Effect of E-cadherin blocking on the total and activated β1-integrin 
expression levels. Both in proliferative (A and B), and non-proliferative (D and E), 
normal S1 cells and MB2 treated cells were immunostained for cell surface expression 
levels of total and activated β1-integrin. The error bars represent standard deviation of 
mean (N=2 for both proliferative cells and non-proliferative cells with 3 samples for each 
condition per experiment). p-value is calculated by comparing control and MB2 treated 
cells at 5 µg/ml concentration. C and F, α-tubulin normalised total levels of β1‐integrin in 
control and MB2 treated proliferative and non-proliferative cells respectively. The error 
bars represent standard deviation of mean (N=2 for both proliferative cells and non-
proliferative cells). p-value is calculated by comparing control and MB2 treated cells at 5 
µg/ml concentration.   
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INTERACTION OF E-CADHERIN WITH ECM AND HR 
Previously, ECM was shown to up-regulate HR in junctioned cells but down regulate it 
in single cells via β1-integrin. My protein localization and expression data showed that 
E-cadherin prevents repair proteins RAD51 and γ-H2AX from entering into the nucleus, 
but does not alter β1-integrin levels. These data prompted the question of whether E-
cadherin was involved in mediating HR or the effect of ECM on HR. Therefore, DR-GFP 
assay was conducted in S1 DR9 cells. S1 DR9 cells are those that have two direct 
repeats of non-functional GFP genes. When one of the GFP genes is cut with I-SceI 
endonuclease (encoded by pBAS), it causes a double strand break. If this break is 
repaired by HR, then the GFP gene becomes functional and the cells can be identified 
and measured by flow cytometry due to the expression of reporter gene in them. GFP 
gene remains non-functional if they are repaired by non-homologous end joining. Using 
this assay the HR frequency was measured.  
To identify whether there is any interaction between E-cadherin, ECM and HR, the DR-
GFP assay was performed under 4 different conditions. The S1 DR9 cells were grown 
up to ~40% confluence and the cells are transfected with pBAS to introduce double 
strand break in the presence and / or absence of ECM and E-cadherin (namely - MB2 & 
- ECM, + MB2 & - ECM, - MB2 & + ECM and + MB2 & + ECM). 4 - 8 days after the 
introduction of DNA break, the HR frequency was measured as GFP positive cells 
under 4 different conditions using flow cytometric analysis. pGFP encoding GFP gene 
was used as transfection control. 
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The HR frequency was found to be higher in MB2 treated when compared to control 
cells in the absence of ECM while in the presence of ECM, MB2 abolishes the effect of 
ECM on HR (Figure 30). These results suggest that E-cadherin is necessary for the up-
regulation effect of ECM on HR. 
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A.                                                         B. 
 
Figure 30. Frequency of HR in the presence and absence of MB2 and ECM. A, HR 
frequency in control and MB2 treated cells without ECM. B, HR frequency in control and 
MB2 treated cells in the presence of ECM. The error bars represent standard deviation 
of mean (N=2) with a minimum of 3 samples per condition in each experiment. p-value 
is calculated by comparing control and MB2 treated cells at 5 µg/ml concentration.   
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INTERACTION OF RAD51, ECM AND HR 
My results showed that E-cadherin is necessary for mediating the up-regulation effect of 
ECM on HR, as well as showing that E-cadherin increases the nuclear accumulation of 
RAD51. This begged the question of whether RAD51 is necessary for the ECM effect 
on HR. Therefore, as a first step to find out the effect of HR and ECM in the absence of 
RAD51, siRNA against RAD51 was used. To identify, the duration during which RAD51 
is down regulated by siRNA I transfected RAD51 siRNA and scramble control, 24 hours 
after plating 300,000 cells in a 6-well chamber plate. 
Lysates were collected from cells transfected with scramble control and RAD51 siRNA 
on day 1, 2, 4 and 7 after transfection. Protein concentration in the lysates was 
measured using BioRad protein determination kit. RAD51 levels in those lysates were 
later measured by performing western blot technique and normalized using their 
respective α-tubulin levels and later by scramble controls. RAD51 siRNA was found to 
be down regulated during day 1 to ~ day 4 (Figure 31).  
Therefore, I planned to introduce double strand break during day1 after RAD51 siRNA 
transfection and measure GFP positive cells to find the effects of HR in the absence of 
RAD51. For this, I plated S1 DR9 cells on T75 flasks. After 28 hours, the cells were 
transfected with RAD51 siRNA and sramble control. Then, the cells were transfected 
with pBAS to induce double strand break on the I-SceI recognition site within the non-
finctional GFP gene 18-19 hours after RAD51 siRNA transfection during which RAD51 
was down regulated. To find out the effect of ECM and HR in the presence and absence 
71 
 
 
 
of RAD51, double strand break was induced under 4 different conditions namely, in the 
absence of ECM and presence of RAD51, in the absence of ECM and RAD51, in the 
presence of ECM and RAD51 and in the presence of ECM and absence of RAD51. 
GFP positive cells were measured 48 hours after pBAS transfection that induces double 
strand break, to measure the frequency of HR under 4 different conditions mentioned 
above (to ensure the experiment was completed within the time frame of RAD51 down-
regulation). Plasmid encoding GFP protein is also transfected for all 4 growth conditions 
to measure the transfection efficiency under each condition and also to normalize the 
results. 
In the absence of ECM, HR was significantly down regulated in RAD51 siRNA 
transfected cells ~9-fold than control cells. While in the presence of ECM, the HR 
frequency is not significantly down regulated in the presence of RAD51 siRNA (Figure 
32). These results could suggest that ECM induces a largely RAD51-independent 
pathway of HR, if the siRNA down-regulation of RAD51 was succesful in the presence 
of ECM as in its absence. To determine this, lysates were collected from cells that were 
treated with scramble siRNA and RAD51 siRNA in the presence and absence of ECM. 
When the lysates were probed for RAD51 on a western blot, I was able to see equal 
down regulation of RAD51 in the RAD51 siRNA treated cells both in the presence and 
absence of ECM (Figure 33). 
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A.                                                                                         
 
 
B. 
 
Figure 31. Down regulation of RAD51 using siRNA. A, western blot containing 
lysates prepared from RAD51 siRNA or scramble sontrol siRNA transfected cells. The 
lysates were collected after 1, 2, 4 and 7 days after siRNA transfection. B, RAD51 levels 
were quantified from the western blot were shown in the form of bar graph. The RAD51 
levels were normalized using their respective scramble control’s RAD51 levels.   
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Figure 32. Effect of RAD51 siRNA on HR in the presence and absence of ECM. 
The figure shows the HR frequency in RAD51 siRNA  and scramble control transfected 
cells in the presence and absence of ECM. The error bars represent standard deviation 
of mean (N=2), a minimum of 3 samples per condition was used in each experiment. p-
value is calculated by comparing HR frequency of scramble control and RAD51 siRNA 
transfected cells in the presence or absence of ECM.   
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Figure 33. RAD51 levels in scramble and RAD51 siRNA transfected cells. Western 
blot shows the levels of RAD51 in the lysates of scramble siRNA and RAD51 siRNA 
transfected S1 cells in the presence and absence of ECM. α-tubulin was used as the 
loading control. 
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β-CATENIN’S ROLE IN HR AND ITS INTERACTION WITH ECM  
Since I was able to see in indirect immunofluorescence and western blot that the β‐ 
catenin levels are higher in the nucleus of MB2 treated cells I was interested in finding 
out whether there was any change in the phosphorylated forms of β catenin. For this I 
probed for phosphorylated forms of β-catenin such as β-catenin Tyr-142, Ser-45 and 
tyr89. I was not able to see any bands in case of phosphorylated β catenin Ser-45 and 
tyr89. But I was able to see a band for phosphorylated β-catenin Tyr-142. There was no 
difference in the signal for phosphorylated β-catenin Tyr-142 in control and MB2 treated 
proliferative and non-proliferative cells (Figure 34). 
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Figure 34. Tyr-142 phosphorylated β-catenin levels in MB2 treated and untreated 
cells. The blot shows phosphorylated β catenin Tyr-142 levels in proliferative control 
and MB2 treated cells within lane 1 and 2. Lane 3 and 4 has lysates from non-
proliferative control and MB2 treated cells. α tubulin was used as the loading control. 
The table below shows the quantification of α-tubulin normalized Tyr-142 
phosphorylated β-catenin levels on the blot. 
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DISCUSSION 
Previously our lab showed that in the presence of ECM and cell-cell junctions ECM 
signaling up-regulated HR whereas in the absence of cell-cell junction ECM signaling 
was found to down regulate HR. Since, in the presence and absence of cell-cell 
junctions ECM signaling effects on HR changes, I was interested in identifying cell 
junction protein(s) that is responsible for interfering with the ECM signaling on HR.  
In mammary epithelial cells, E-cadherin is the main adherens junction protein that is 
involved in attaching the adjacent cells together. Reduction in E-cadherin expression 
has been found in tumor cells [46].  It has also been reported that inactivating mutations 
of E-cadherin gene are highly frequent in infiltrating lobular breast carcinomas and 
diffuse gastric carcinomas [47]. E-cadherin is the second most frequently mutated gene 
in breast cancer [48]. 
Therefore, to see whether this cancer relevant protein, E-cadherin is the cell-cell 
junction protein that is interacting with HR, I blocked E-cadherin protein function of S1 
cells and asked if this altered DNA repair protein localization, expression and HR 
function. E-cadherin blocking in the non-tumorigenic S1 cell lines resulted in cell 
scattering, loss of contact inhibition, increased proliferation as well as movement of β-
catenin into the nucleus. 
It is interesting to note that although S1 cells are non-transformed there are other 
examples of non-transformed cells responding similarly to E-cadherin blocking. For 
example, in ES cells it has been shown that loss of E-cadherin was found to result in 
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nuclear localization of β-catenin [49]. These results suggested that S1 cells are 
appropriate for studying loss of E-cadherin function and its downstream effector β-
catenin. 
Blocking E-cadherin in both proliferating and non-proliferating S1 cells increased γ-
H2AX foci in the nucleus. Large nuclear foci of RAD51 were present in E-cadherin 
blocked cells but not in normal S1 cells. These results suggested that E-cadherin blocks 
the nuclear localization of γ-H2AX and RAD51. This could indicate that proper E-
cadherin containing cell-cell junctions are important in preventing endogenous DNA 
damage. When E-cadherin is blocked, cell scattering could upset cellular homeostasis 
resulting in increased endogenous DNA damage. Reactive oxygen species are one 
potential DNA damage-causing agent that could be induced [50]. Increased DNA 
replication and stalled forks could be another way of inducing DNA repair foci in the 
absence of exogenous damage. Since our results showed that E-cadherin blocking 
increases γ-H2AX foci even in the absence of proliferation it is not necessary to invoke 
the S phase replication blocks in explaining the nuclear accumulation of these DNA 
repair proteins. 
It is interesting to note that in the absence of added ECM, blocking E-cadherin up-
regulated HR as well as increased the nuclear γ-H2AX and RAD51. These results were 
consistent with E-cadherin mediated junction signaling modulating HR via γ-H2AX and 
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RAD51. In fact, in the absence of ECM we found HR to be almost completely RAD51 
dependent. In exact opposition to these results, we found both E-cadherin and RAD51 
to act very differently for HR in the presence of ECM. RAD51 was not necessary for 
most HR in the presence of ECM but E-cadherin was entirely required i.e, E-cadherin 
prevents HR in the absence of ECM but it is needed for HR in the presence of ECM. 
In trying to decipher the E-cadherin pathway components in the HR regulation, it is 
noteworthy to mention that our results revealed an interaction between E-cadherin, an 
adherens junction protein, HR proteins and movement of β-catenin into nucleus. 
Various studies have shown that β-catenin interacts with LEF/TCF transcription factors 
in the nucleus [28]. So, transcriptional regulation of DNA repair related proteins could 
contribute to the observed HR effects. Alternatively, β-catenin could signal via multiple 
phosphorylation events to cytoplasmic signaling components. Of these Tyr-142, Tyr-86 
and Ser-45 have been studied well. 
Phosphorylation at Tyr-142 abolishes the interaction between β-catenin and alpha-
catenin. pp60c-src phosphorylates β-catenin at Tyr-86 and Tyr-654 reducing its affinity 
for E-cadherin [39]. Phosphorylation at Ser-45 by an unknown kinase is required for the 
GSK-3 to further phosphorylate β-catenin at Thr-41, Ser-37 and Ser-33 that results in 
beta-catenin ubiquitination and proteasome-dependent degradation [40].  
Finally to find out whether there is any change in the amount of phoshorylated β-catenin 
levels in the normal S1 cells and MB2 treated cells, I probed for phosphorylated β-
catenin Tyr142, Ser45 and Tyr86 by western blot analysis. I was not able to see any 
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difference in the amount of phosphorylated β-catenin Tyr142 levels between control and 
MB2 treated cells. Moreover, the levels of phosphorylated β-catenin Tyr86 and Ser45 
proteins remained undetectable in control and MB2 treated cells. Thus I was not able to 
see any change in the three phosphorylated forms of β-catenin in control and MB2 
treated cells.  
Apart from these phosphorylated forms of β-catenin, there are also other mutant forms 
(especially at the N-terminal end) of β-catenin that are associated with cancer and have 
the ability to enter into the nucleus. For example, β-catenin that lacks Ser 45 (3bp 
deletion) is a mutant that is not affected by APC leading to an increase in β-catenin-
LEF4 complex formation in the nucleus. This mutant is seen in colon cancer tumor cell 
line HCT116. Another mutant seen in SW48 colon cancer tumor cell line has a single 
missense mutation that replaces Ser to Tyr. This mutant is also not affected by APC 
leading to an increase in β catenin-LEF4 complex formation in the nucleus. There are 
other N-terminal truncated β catenin mutants that do not have GSK-3beta 
phosphorylation sites on β catenin. Therefore testing these mutants for their effect on 
HR could also give some insights into the role of β catenin in HR. HR experiments 
related to β catenin mutants or siRNA against β catenin and E-cadherin will help us to 
understand further the role of E-cadherin and β catenin in DNA double strand break 
repair directly, as well as in combination with ECM signaling.  
For ECM signaling and E-cadherin cross talk we observed here, the primary candidate 
protein was β1-integrin. However, we found that blocking E-cadherin did not alter this 
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integrin, making it less likely the mediator of ECM to E-cadherin cross talk in modulating 
HR. However, experiments blocking β1-integrin need to be performed to determine if it 
is functionally relevant for the E-cadherin dependence of the ECM effect on HR. 
These results leave us with a model (Figure 35) indicating that ECM can act as a 
genome stability enhancer via inducing HR. For this, intact cell-celljunctions are needed 
and E-cadherin is necessary for such ECM mediated genome stability. Given that both 
proper cell-ECM interactions and proper cell-cell interactions are needed for tissue 
integrity, for cells requiring adhesion for cell survival, our results indicate that both 
adhesion pathways are needed for proper DNA repair pathway choices and thus 
maintenance of a stable genome. Based on our model, we predict that in cancer cells 
with either compromised cell-ECM or cell-cell junctions HR will be down regulated 
resulting in instability. 
In conclusion, E-cadherin was found to interact with DNA repair proteins and this could 
occur through ECM signaling pathway since, HR experiments have shown that there is 
a cross-talk between E-cadherin and ECM. And this cross talk could be via β-integrin 
other than β1 type of integrin. Thus E-cadherin was found to have a new role in DNA 
repair apart from its role in cancer. Moreover, HR occurs in a RAD51-independent 
manner in the presence of ECM and E-cadherin would interact with this pathway as in 
the absence of E-cadherin, HR is down regulated in the presence of ECM. Apart from 
this I believe that other than E-cadherin, β-catenin should also be involved in this HR 
pathway directly or indirectly since I was able to see changes in the nuclear β-catenin 
levels in MB2 blocked cells. Further investigation on the various nuclear forms of β-
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catenin (mutants/phosphorylated forms) in HR will help us to understand its involvement 
in the E-cadherin role on HR. Finally, understanding the inter-relationship between E-
cadherin, genomic stability and β-catenin will contribute in further understanding normal 
breast cell processes, how they get transformed and contribute later on cancer 
progression.  
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Figure 35. Model for adherens signaling effects on HR and genome stability. 1, In 
the presence of both ECM and cell-cell junctions, ECM up-regulates HR. This requires 
E-cadherin and HR occurs in a RAD51-independent manner - stable genome 
expected. 2, In the absence of cell-cell junction (example: single cells), ECM blocks HR 
as well as downregulating RAD51 and γ-H2AX foci– unstable genome expected. 3, In 
the absence of ECM, E-cadherin blocks HR and nuclear RAD51 and γ-H2AX – 
unstable genome.  
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